ArticleJournal of otology2025
Novel Approach to Osteoradionecrosis of the Temporal Bone: Vascularized Obliteration with Gracilis Muscular Free Flap.
Article in Journal of otology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoradionecrosis of the temporal bone (ORN-TB) is usually controlled with conservative measures. However, a temporal bone resection may be required in unresponsive cases. The reconstruction of the resulting defects may be challenging because of the radiation damage to regional tissues. As a result, distant free flaps may be an optimal choice. For instance, the gracilis muscular free flap (GMFF) has consistent vascular anatomy and can be used to reconstruct small defects. We report three cases of uncontrolled ORN-TB requiring an extensive temporal bone resection followed by vascularized obliteration with a GMFF. The patients reported complete control of the main otologic symptoms (otorrhea, otalgia, and aural fullness) and optimal functional and aesthetic outcomes. Finally, the patients reported significant improvement in quality of life despite early postoperative complications. To our knowledge, the GMFF had not been used to obliterate temporal bone defects in patients with ORN-TB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.